chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within a few hours of immunization arrhythmias began and continued throughout the day and night. The arrhythmia apparently began as sinus tachycardia and became supra ventricular tachycardia, then atrial fibrillation and subsided to sinus tachycardia. as recorded by in home ecg machine. The arrhythmias continued until October 10 in the PM and reverted to sinus rhythm. Since then sinus tachycardia has continued intermittently. As of October 12 patient has had several multi hour sinus tachycardia events which continue to the present date of this report.
pt recv vax 22AUG96 & 1 days p/vax pt exp nausea, vomiting, lethargy & low grade temp;
Bilateral armpit pain/ache Joint ache in all extremities Left groin ache, back of left knee pain with intermittent tingling and burning sensation Left leg ache Extremities weakness and minor muscle spasms Post nasal drip Fatigue Slightly elevated blood pressure Heart fibrillation
Rash around 21 days. Fluid drained from knee 09/04/2002.
Pt had a 1/2 dollar size rash 2 days after shot with heat, redness, itching and tenderness. Next day when called pt said heat is gone down (no heat), no swelling just red with rash and itchy - pt comes back 4 days after saying it's blue and black.
Reported sharp chest pain on the middle/left side. Initially it was constant pain and hurt more when she took normal breaths. Symptoms resolved. She saw her PCP.
Exhausted; body aches; joint hurt; head ache; sweating; immediately cold tongue then felt as tho semi numbness.; immediately cold tongue then felt as tho semi numbness.; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: Er8731; Expiration date: unknown) via an unspecified route of administration, administered in Arm Left on 23Jul2021 13:00 as DOSE NUMBER UNKNOWN, SINGLE and patient also received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, lot number: Ew0172; Expiration date: unknown) via an unspecified route of administration, administered in Arm Right on 23Jul2021 as DOSE NUMBER UNKNOWN, SINGLE both for COVID-19 immunization. Relevant medical history, concurrent conditions and concomitant medications were not reported. Patient had not known allergies. Patient had not relevant past drug history. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine nor received any other medications within 2 weeks of vaccination. Prior to vaccination, the was patient diagnosed with COVID-19. On 23Jul2021 13:00 patient experienced exhausted, body aches, joint hurt, head ache, sweating, immediately cold tongue then felt as tho semi numbness, immediately cold tongue then felt as tho semi numbness. On second shot immediately cold tongue then felt as tho semi numbness. Took full 4 weeks until patient felt woke up felt like patient had no COVID symptoms. Adverse event resulted in emergency room visit. Patient had received treatment for AEs (over the counter medicines). This report was not serious. Since the vaccination, has the patient did test for COVID-19 (Nasal swab) on 18Aug2021 which was negative. The outcome of event was recovered on an unspecified date in Jul2021.  Follow-Up (02Sep2021): Follow-up attempts are completed. No further information is expected.
Tiredness and lack of appetite - days 2 - 7 Cough (with mucus) - days 2 - 12 and ongoing
having stomach issues; This is a spontaneous report from a contactable consumer (patient). This 79-year-old female patient received the 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. Medical history and concomitant medications were unknown. The patient explained that the hospital gave her a document presenting an interval varying between "17-24 or 28 days" for the second dose of the COVID-19 vaccine. She stated that her appointment for the second dose was 17 days after the first dose, and asked if this timing was "legitimate". The patient had first dose of covax, inquiring on the change of having second dose after 17days instead of 21 days. The patient had to hang up, stated she was having stomach issues, was not able to transfer. Outcome of the event was unknown.    Information on the lot/batch number has been requested.
Continuous nausea after AVA #1. Nausea, chronic diarrhea (2 months) with mild abdominal pain and severe fatigue after AVA #2. Also severe generalized myalgia. Swelling of the hands and finger joints. Severe back pain and spasm lasting several weeks.  Still has chronic fatigue, trembling of hands.
Pt experienced a mild form of rash without vesicles. Diffuse red papules lasting 6 days after usual prodrome.
chills only; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills only) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced CHILLS (chills only). At the time of the report, CHILLS (chills only) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications was reported Treatment information was not provided   This case was linked to MOD-2021-054634 (Patient Link).
accidentally received a dose of Shingrix instead of the varicella vaccine; accidentally received a dose of Shingrix instead of the varicella vaccine; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 30-day-old female patient who received Herpes zoster (Shingrix) (batch number 22M3K, expiry date 29-FEB-2024) for prophylaxis.   On 28-APR-2023, the patient received the 1st dose of Shingrix. On 28-APR-2023, an unknown time after receiving Shingrix, the patient experienced wrong vaccine administered (Verbatim: accidentally received a dose of Shingrix instead of the varicella vaccine) and inappropriate age at vaccine administration (Verbatim: accidentally received a dose of Shingrix instead of the varicella vaccine). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown.   Additional Information: GSK Receipt Date: 26-JUN-2023 The reporter reported that a patient accidentally received a dose of Shingrix instead of the varicella vaccine and wished to know how to proceed.  The information about the vaccine, patient and event given.  The Vaccine Administration Facility was the same as Primary Reporter. They accepted to receive follow up and to have the case escalated. The reporter consented to follow up.  The patient received accidentally received a dose of Shingrix instead of the varicella vaccine, which led to wrong vaccine administered and inappropriate age at vaccine administration.
Information has been received from a doctor of pharmacy concerning a female (age unknown) who was vaccinated with a first and second dose of pneumococcal vaccine 23 polyvalent (manufacturer unknown). The patient received the vaccines within six months of reciving the first. The second dose not comply with the recommend dosages schedule. The patient reportedly was 'fine" for about a week and then she started to develop back pain and became weak. It was noted that the reporter did not know which pneumoccal vaccine the patient revealed. The patient sought unspecified medical attention. No further information is expected.
Fast onset of Tiredness occurred at 11:00pm until 11:00am..  Sore arm at injection site lasted for 4 days.   Trouble breathing, felt like a weight on my chest and it was difficult to speak lasted for 90 minutes.
SEVERE NAUSEA/VOMITING, DIZZINESS, HEADACHE, LOSS OF HEARING, BLURRED VISION.
Seizure - initially tonic, evolving to fine generalized tremor lasting one minute with post event sleep x 10-20 min, woke confused x few seconds. Immunizations given 9/7/11, event occurring that evening with new onset URI but no fever. No significant med history. Dad w/ h/o febrile seizures, no other FHx of seizure.
Nausea, vomiting, fever, fatigue, chills; cellulitis, lymphangitis; treated with Keflex and Bactrim.
pt recv vax 22AUG96 & lab eval on 4SEP96 revealed a negative titer;pt was also noted that the pt devel a positive core antibody (date of test unk);
High fever (6 days) - breathing problems & wheezing, pale, very weak, rapid heartbeat, nausea, diarrhea, headaches.
Swollen red bumps on Left arm (site of Fluzone injection) from site to elbow.  No itching.
within 1/2 an hour of receiving the 2nd shot, while driving home from  dodger stadium, i was struck by a horrible headache and severe dizziness. that was over 6 months ago and these same symptoms persist to this day. they are sometimes accompanied by nausea, fatigue, and anxiety. i have seen my internist 3 times, an allergist, an ENT and a neurologist all in an effort to aleve these symptoms. nothing has worked so far.
Vaccines were given 03-09-17 in am. By that evening R-arm was swollen, red, warm and pruritic. Concurrent rash developed on both calves, R-wrist. The rash on legs and wrist burned. Applied moisturizer. I saw her 03-13-17 and all things had improved.
pt recvd vax;was at school when teacher said eyes went to back of head x 2; did not lose consciousness;did c/o extreme thirst all day after event; saw PMD at 2pm; afebrile, curried 4 days after immun;
pt recvd vax;in eve of 9aug, devel inc t of 102; laste x 48 hrs; rt deltoid tender for a few days but swollen for 2 wks;
Local swelling onset 01/14/2012, heat radiating from injection site onset 01/14/2012, rash at injection site, approx size 2.5" diameter onset 01/15/2012, rash grew approx size 5-6" diameter 01/17/2012.
Employee received covid vaccine at 813am. At 830, he reported flushing sensation on his face.  Vital sign at 830: BP 109/81, HR 80, O2 99%.  He denies wheezing, sob, chest discomfort, sore throat, difficulty breathing, pruritic. Employee was provided fluids and reports symptoms gradually improved.  On assessment, employee's face was flushed, mild erythema on the upper arm. No angioedema. Lung sounds clear. Heart sounds normal. No acute respiratory distress. Employee was observed closely in clinic. Symptoms improved. At 855, BP 107/79, Hr 72, O2 100%. Employee was discharged from clinic to return home. He was instructed to closely monitor his symptoms. If his symptoms worsen or persist, he needs to go to urgent care or go to ED. He stated understanding. He left in stable condition. No acute distress.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine which expired on 01-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 08-Apr-2022) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination. No Medical History information was reported. On 08-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 08-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine which expired on 01-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 08-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received vaccine which expired on 01-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 08-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. The pharmacist thought that the vaccine will expire in Jun-2022 however the vaccine expired on 01-Apr-2022. The vial did not undergo any temperature excursions. No treatment medications were provided.
Nasal drainage; coughing; tight chest; nose bleed from left side of nose; chest pain; This is a spontaneous report from a contactable Consumer (patient). A 61-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: EN6198), via an unspecified route of administration, administrated in Left arm on 04Mar2021 10:45 (age at the time of vaccination 61-years-old), as a single dose for COVID-19 immunization. The patient's medical history included blood platelets tend to be low, when last tested 26Jun2020 it was 143 (x10E3/uL); and on 11Feb2021, patient took Hepatitis A, and hepatitis B vaccine, dose number 3, on Left arm. The patient's concomitant medications were not reported. Patient had no known allergies. On 05Mar2021 10:15, the patient experienced Nasal drainage, coughing, tight chest, nose bleed from left side of nose, and chest pain. On 26Jun2020, the patient underwent lab tests and procedures which included Platelet count: 143, low. No treatment was received. No covid prior vaccination. No covid tested post vaccination. The outcome for all the events was recovered.  No follow up attempts are possible. No further information is expected.
Pt recvd vax 17APR92 & 24APR92 devel a rash & myalgia on 26APR92 & exp nausea;
1628 ? Patient received first dose of Pfizer vaccine.  She reported a history of allergic reactions in the past and was thus observed for 30 minutes following her injection time.  1704 ? Vitals: 99% sp02, 192/101 BP.  Patient reported symptoms of itching of face, scalp, eyes, and hands.  25 mg Benadryl given by Observer.  Patient placed on continuous sp02 monitor.  No SOB, cough, or wheezing at this time.  1710 ? Observers called ED Nurse to let them know we would likely be sending a patient their way.    1715 - Observer was advising patient?s husband to take her to the ED when Coordinators were alerted to situation. contacting ED and allowing patient to transport themselves is not our protocol and Coordinators took control of the situation at this time.  1717 ? 1720  ? Patient moved by wheelchair to private area in the library for further evaluation.   Vitals: 99% sp02, 200/119, BP, 90 HR.  assessed patient.  Rash but not hives are present on her chest.  There is mild end-expiratory wheezing consistent with asthma history.  No airway edema.  No trouble speaking or swallowing.  She is mildly diaphoretic but neurologically intact.    1720 ? Rapid response called for transport to ED.  Sp02 98 ? 99.  1722 - Patient is starting to have increased wheezing with sp02 holding at 98%.  She doesn?t have her inhaler.  1727 ? Rapid response called to say transport is 5 ? 10 minutes away.  Patient still on monitor.  No visible airway edema.  Starting to cough and bilateral upper extremities mildly edematous.  She notes her back is itching in addition to chest.    1728 ? After briefly explaining procedure to patient and obtaining verbal consent, 0.3 mg Epi Pen injection given to right lateral thigh.  Vitals 192/133 BP, 91 HR, 99% 02.  1731 ? EMS arrives.  Itching, wheezing, and cough have improved.  Report given to EMS.  Patient transported by stretcher to ED.  Report had previously been given to ED and updates since then were given to EMS.
15Jan91 @ 530am, noted redness of both eyes & blood vessels appeared engorged, No itching burning or light sensitivity. Irrigated several times/w Visine, condition lasted 3 hrs. Same rxn /p 1st vax
Patient received Tdap and Menactra vaccine and approximately 5 minutes later was dizzy, nauseated, diaphoretic and vomited times one.  He was slow to respond to stimuli with increased pallor.  VS taken, O2 applied and labs drawn. Blood glucose 110, continued to be weak, dizzy, and slow to respond.  Sent to hospital via ambulance for evaluation.  B/P 130/90, pulse 88.  Monitored in ED for 1.5 hours then discharged with DX. vasovagal syncope.
No adverse event; Vaccine administrators gave a bivalent dose as a second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Vaccine administrators gave a bivalent dose as a second dose) and NO ADVERSE EVENT (No adverse event) in a 48-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7168B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Mar-2023, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Mar-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced WRONG PRODUCT ADMINISTERED (Vaccine administrators gave a bivalent dose as a second dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Vaccine administrators gave a bivalent dose as a second dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Vaccine administrators gave a bivalent dose as a second dose).    The concomitant medication was not reported by reporter. The patient's first Moderna dose was given on 09-Dec-2022 batch number Unknown for COVID-19 prophylaxis. The pharmacist stated one of the vaccine administrators gave a bivalent dose as a second dose yesterday 29-Mar-2023. He called and reported it to unknown, who was the federal partner. One of the things he was told to do was to call Moderna and get guidance for what they should do for the patient. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. The treatment medication was not reported by reporter.
Information has been received from a health professional concerning a 28 year old female who on 28-AUG-2007 was vaccinated with the first dose of GARDASIL (lot# 658558/1061U) into her left buttocks. Not long after first dose, migraine headache started. On 25-OCT-2007, the patient was vaccinated with the second dose of GARDASIL (lot# 654539/0742U) into her left gluteus and on 25-FEB-2008, was vaccinated with the third dose of GARDASIL (lot# 655327/1287U) into her left gluteus. Concomitant therapy included ALESSE. On 01-MAY-2009, the patient passed out and was hospitalized, a spinal tap was performed. The patient had migraine headache started not long after the first injection. The patient was seeing a neurologist. A MRI performed showed abnormal results. The patient developed demyelination in brain. Questionable Lupus. Upon internal review, questionable lupus was determined to be an other important medical event. Additional information has been requested.  9/16/09 Received vaccine & GYN medical records. Records reveal patient experienced wt loss & fatigue.  On 5/1 had seizure, hospitalized & neuro eval done.  10/6/09 Neurological consult received service dates 5/1/09 to 5/21/09. Assessment: Migraine Presented with c/o severe bifrontal headache and episode of syncope. Transient loss of consciousness. Episodes of weakness associated with headaches, visual disturbance, migraine headaches for past year associated with use of oral contraceptives.
SHOT ARM GOT SORE AND NUMB, SAME SIDE NECK STIFFNESS, CHILLS, TASTE DISTURBANCE (METALLIC)
aching lasted one night; painful swelling under left arm  lasted about 6 days.; Chills; painful swelling under left arm  lasted about 6 days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Sep2021 16:15 (Lot number: 30135BA) at the age of 73 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "penicillin allergy" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose 1, Batch/Lot No: EN6198, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 26Feb2021, when the patient was 72 years old, for covid-19 immunization; Bnt162b2 (Dose 2, Batch/Lot No: ER2613, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 18Mar2021, when the patient was 72 years old, for Covid-19 immunization. The following information was reported: PAIN (non-serious) with onset 28Sep2021, outcome "recovered", described as "aching lasted one night"; PERIPHERAL SWELLING (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 28Sep2021, outcome "recovered" and all described as "painful swelling under left arm lasted about 6 days."; CHILLS (non-serious) with onset 28Sep2021, outcome "recovered", described as "Chills". Therapeutic measures were not taken as a result of pain, peripheral swelling, chills, pain in extremity.  Additional information: The patient did not receive other vaccine same date product. The patient did not receive other vaccine in four weeks. The patient received other medications in two weeks. The patient did not have covid prior vaccination. The patient did not get covid tested post vaccination.  No follow-up attempts are possible. No further information is expected.
Headache, Myalgia, Fever, RLQ PAIN WHICH RESOLVED AFTER 24 HR  Narrative:  Other Relevant History:
Patient already having paresthesia, which occurred 2 days after first immunization; although these were significantly improving. Patient reported symptoms occurred 6/22/2021. Chest pressure, palpitations and blurry vision. Please note patient continues to experience paresthesia on face/body.
11.5.22 date of vaccination  11.6.22 sore deltoid  11.7.22 sore neck and shoulders  11.8.22 whole body aches, difficulty walking up stairs, 11.9.22 weakness, tremors, continuation of whole body aches, pain with movement of any muscle group 11.10.22 dropping items, grip weakness, whole body aches, continued painful muscle movements of all muscle groups  11.11.22 ER visit. Rhabdomyolysis diagnosis. Hospital admission
The patient received and improperly stored dose of PNEUMOVAX 23.; The patient was given PNEUMOVAX 23 that was recalled.; This spontaneous report was received from a Medical Assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported.   On an unknown date, the patient was vaccinated with an improperly stored dose of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) 0.5 milligram dose (strength, route, frequency, and anatomical location were unknown) with lot # S036495, and expiration date 13-SEP-2021 for prophylaxis. On 26-OCT-2020, the pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) vaccine was recalled. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S036495; expirationdate: 13-SEP-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
Patient reports had chest pain from chest into back ( I thought I was having a heart attack). Patient reports this pain lasted for 6 hours the night she received her COVID 19 vaccine. Patient also reports had nausea and vomiting for 2 hours the night of her COVID 19 vaccine. Pt reports she discussed the above with her allergist doctor and he advised her not to receive the second COVID 19 vaccine.